SEC Filing Summary: Tivic Health Systems, Inc. (TIVC)
Business Context and Reporting Period
This Form 8-K was filed on August 14, 2025, by Tivic Health Systems, Inc., a Delaware corporation. The filing serves to disclose the Company's financial results for the quarter ended June 30, 2025, via a press release furnished as Exhibit 99.1. The registrant is an emerging growth company listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release (Exhibit 99.1) referenced in Item 7.01 but are not detailed in the body of this 8-K document.
Material Changes
No specific material changes versus the prior comparable period are quantified in this filing. The document indicates that the results for the quarter ended June 30, 2025, are disclosed in the attached press release.
Guidance, Outlook, and Risks
The filing includes a standard "Forward-Looking Statements" section. Management notes that statements involving terms such as "anticipates," "expects," and "believes" are subject to substantial risks and uncertainties. Actual results may differ materially from those expressed due to known and unknown factors. The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting liability for the forward-looking content.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 14, 2025) for specific Q2 2025 financial figures.
- Verify the Company's cash position and runway given the lack of specific liquidity data in this summary filing.
- Assess the impact of the "emerging growth company" status on financial reporting standards.
- Confirm the accuracy of forward-looking statements against actual operational performance in subsequent filings.